PT Pyridam Farma Tbk (ISX:PYFA) Marketable Securities: Rp3,197 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
67 GF Score
Price Rp212.00
GF Value Rp230.61
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Marketable Securities?

PT Pyridam Farma Tbk ISX:PYFA +1.92% 67 Marketable Securities is Rp3,197 Mil as of Jun. 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 67/100 and a GF Value™ of Rp230.61 (Fairly Valued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PT Pyridam Farma Tbk's Marketable Securities for the quarter that ended in Jun. 2026 was Rp3,197 Mil.

PT Pyridam Farma Tbk's annual Marketable Securities increased from Dec. 2023 (Rp0 Mil) to Dec. 2024 (Rp1,642 Mil) but then declined from Dec. 2024 (Rp1,642 Mil) to Dec. 2025 (Rp1,100 Mil).

PT Pyridam Farma Tbk  (ISX:PYFA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PT Pyridam Farma Tbk Marketable Securities Related Terms

PT Pyridam Farma Tbk Marketable Securities Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Marketable Securities Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1,641.71 1,100.00

PT Pyridam Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,110.30 1,237.81 1,100.00 2,003.32 3,196.78
ISX:PYFA
67GF Score
PT Pyridam Farma Tbk ISX:PYFA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of Rp3,197 Mil mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Marketable Securities of Rp3,197 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Marketable Securities too high?
PT Pyridam Farma Tbk's current Marketable Securities is Rp3,197 Mil. Overall, PT Pyridam Farma Tbk has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Marketable Securities compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Marketable Securities of Rp3,197 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Marketable Securities is Rp3,197 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp230.61, compared to a current price of Rp212.00 — trading 8.1% below its estimated fair value. The current Marketable Securities is Rp3,197 Mil. PT Pyridam Farma Tbk's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Marketable Securities is Rp3,197 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued. The current stock price of Rp212.00 is trading 8.1% below its estimated GF Value™ of Rp230.61. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Marketable Securities: Rp3,197 Mil
  • GF Value™: Rp230.61 vs. price of Rp212.00 (8.1% below fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
67GF Score

Get the complete analysis for ISX:PYFA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp212.00
Price
Rp230.61
GF Value